These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


123 related items for PubMed ID: 8868301

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Involvement of neurotransmitters in the 'anxiolytic-like' action of atrial natriuretic peptide in rats.
    Bíró E, Tóth G, Telegdy G.
    Neuropeptides; 1995 Oct; 29(4):215-20. PubMed ID: 8584139
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Blunted natriuresis and abnormal systemic hemodynamic responses to C-type and brain natriuretic peptides in rats with cirrhosis.
    Komeichi H, Moreau R, Cailmail S, Gaudin C, Lebrec D.
    J Hepatol; 1995 Mar; 22(3):319-25. PubMed ID: 7608483
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. C-type natriuretic peptide exerts effects opposing those of atrial natriuretic peptide on anxiety-related behaviour in rats.
    Montkowski A, Jahn H, Ströhle A, Poettig M, Holsboer F, Wiedemann K.
    Brain Res; 1998 May 11; 792(2):358-60. PubMed ID: 9593994
    [Abstract] [Full Text] [Related]

  • 9. Anxiolytic activity of intraventricularly administered atrial natriuretic peptide in the rat.
    Bhattacharya SK, Chakrabarti A, Sandler M, Glover V.
    Neuropsychopharmacology; 1996 Aug 11; 15(2):199-206. PubMed ID: 8840356
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Isatin (Indole-2, 3-dione) inhibits natriuretic peptide-induced hyperthermia in rats.
    Pataki I, Adamik A, Telegdy G.
    Peptides; 2000 Mar 11; 21(3):373-7. PubMed ID: 10793219
    [Abstract] [Full Text] [Related]

  • 13. C-type natriuretic peptide can modify the acute and chronic effects of morphine.
    Babarczy E, Vízi Z, Tóth G, Telegdy G.
    Neuropeptides; 1995 Sep 11; 29(3):145-9. PubMed ID: 8538875
    [Abstract] [Full Text] [Related]

  • 14. Cyclic guanosine monophosphate responses to atrial natriuretic factor, brain natriuretic peptide, but not C-type natriuretic peptide, and the characterization of their receptors in rat medullary thick ascending limb.
    Luk JK, Wong EF, Sun A, Wong NL.
    Metabolism; 1994 Dec 11; 43(12):1531-5. PubMed ID: 7990707
    [Abstract] [Full Text] [Related]

  • 15. BOC-CCK-4, CCK(B)receptor agonist, antagonizes anxiolytic-like action of morphine in elevated plus-maze.
    Kõks S, Soosaar A, Võikar V, Bourin M, Vasar E.
    Neuropeptides; 1999 Feb 11; 33(1):63-9. PubMed ID: 10657473
    [Abstract] [Full Text] [Related]

  • 16. The action of isatin (2,3-dioxoindole) an endogenous indole on brain natriuretic and C-type natriuretic peptide-induced facilitation of memory consolidation in passive-avoidance learning in rats.
    Telegdy G, Adamik A, Glover V.
    Brain Res Bull; 2000 Oct 11; 53(3):367-70. PubMed ID: 11113594
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Involvement of the nucleus accumbens shell dopaminergic system in prelimbic NMDA-induced anxiolytic-like behaviors.
    Ahmadi H, Nasehi M, Rostami P, Zarrindast MR.
    Neuropharmacology; 2013 Aug 11; 71():112-23. PubMed ID: 23566820
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The pharmacology of VA21B7: an atypical 5-HT3 receptor antagonist with anxiolytic-like properties in animal models.
    Artaiz I, Romero G, Zazpe A, Monge A, Calderó JM, Roca J, Lasheras B, Del Río J.
    Psychopharmacology (Berl); 1995 Jan 11; 117(2):137-48. PubMed ID: 7753959
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.